Better Therapy for Hear
A look at the urgent need for more sensitive diagnostic tests and therapeutic medical devices for myocardial infarction.
Read the full article at: www.mddionline.com
Continue Reading »The Call for Advanced Therapy & Devices to Treat Hepatic Fibrosis
Screening tests and devices are needed to prevent this disease and more research needs to be done to find effective treatments.
Read the full article at: www.mddionline.com
Continue Reading »Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis
Quanterix Granted Breakthrough Device Designation from U.S.FDA for NfL Test for Multiple Sclerosis – read this article along with other careers information, tips and advice on BioSpace…
Read the full article at: www.biospace.com
Continue Reading »T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel – read this article along with other careers information, tips and advice on BioSpace…
Read the full article at: www.biospace.com
Continue Reading »R2 Technologies Reaches First Year Commercial Milestone of Shipping 100 GLACIAL® Devices
R2 Technologies Reaches First Year Commercial Milestone of Shipping 100 GLACIAL® Devices – read this article along with other careers information, tips and advice on BioSpace…
Read the full article at: www.biospace.com
Continue Reading »Still looking to trim the fat, Acutus sells line of heart devices to Medtronic for $50M upfront
If there’s a name for the much less exciting inverse of a shopping spree, Acutus Medical is on it.
Read the full article at: www.fiercebiotech.com
Continue Reading »Covestro Debuts Sustainable Proof-of-Concept Drug Delivery Device
The sustainable demo product by Covestro highlights the company’s medical-grade polycarbonates.
Read the full article at: www.mddionline.com
Continue Reading »FDA Considers New Approach to Improve Safe Disposal of Prescription Opioid Analgesics, Decrease Unnecessary Exposure to Unused Medication | FDA
The U.S Food and Drug Administration established a public docket to consider adding a mail-back envelope requirement to the Opioid Analgesic Risk Evaluation and Mitigation Strategy to require that all opioid analgesics, including immediate-release, extended-release, and long-acting formulations, …
Read the full article at: www.fda.gov
Continue Reading »FDA ramps up cybersecurity efforts with stricter guidance for devicemakers
Important things come on a quadrennial basis: leap years, presidential elections, the Olympics and, apparently, edicts from the FDA about the need for heightened cybersecurity measures to protect c…
Read the full article at: www.fiercebiotech.com
Continue Reading »Abbott picks up the pace with FDA approval of removable, long-lasting leadless pacemaker
Though the FDA approval for Abbott’s first leadless pacemaker comes several years after its competitor Medtronic achieved the feat, the devicemaker is aiming to up the tempo.
Read the full article at: www.fiercebiotech.com
Continue Reading »